This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: China Pharmaceutical University. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Zhiyu Li: Innovator in Immune Regulation
Introduction
Zhiyu Li is a prominent inventor based in Nanjing, China. He has made significant contributions to the field of immune regulation through his innovative research and patents. His work focuses on developing compounds that can effectively activate innate immune pathways to combat tumor cells.
Latest Patents
Zhiyu Li holds a patent for a benzo[b]selenophene STING regulator, which includes a preparation method and its uses. This invention is designed to serve as an immune regulator, effectively activating an innate immune regulation pathway to kill tumor cells. The structure of the compound is detailed in Formula I, showcasing its potential in pharmaceutical applications.
Career Highlights
Zhiyu Li is affiliated with China Pharmaceutical University, where he conducts his research and development. His work has garnered attention for its innovative approach to immune regulation, contributing to advancements in cancer treatment.
Collaborations
Zhiyu Li collaborates with notable colleagues, including Jinlei Bian and Xi Feng. Their combined expertise enhances the research efforts at China Pharmaceutical University, fostering an environment of innovation and discovery.
Conclusion
Zhiyu Li's contributions to the field of immune regulation through his patent and research at China Pharmaceutical University highlight his role as a key innovator. His work has the potential to make significant impacts in the treatment of tumors and advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile